China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · Real-Time Price · USD
1.890
-0.020 (-1.05%)
May 5, 2025, 2:36 PM EDT - Market open

China Pharma Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
64452319
Upgrade
Market Cap Growth
12.27%12.27%-19.49%-78.32%17.59%88.26%
Upgrade
Enterprise Value
988133026
Upgrade
Last Close Price
1.912.336.0547.95241.30222.90
Upgrade
PS Ratio
0.740.990.570.612.371.79
Upgrade
PB Ratio
0.800.580.541.153.802.43
Upgrade
P/TBV Ratio
5.864.250.952.003.892.48
Upgrade
EV/Sales Ratio
2.021.721.141.603.102.42
Upgrade
EV/EBITDA Ratio
--4370.46-131.65259.95
Upgrade
Debt / Equity Ratio
0.460.460.622.042.080.93
Upgrade
Debt / EBITDA Ratio
--58.59-39.1037.57
Upgrade
Asset Turnover
0.290.290.410.400.440.50
Upgrade
Inventory Turnover
2.172.172.052.552.642.44
Upgrade
Quick Ratio
0.180.180.310.200.530.13
Upgrade
Current Ratio
0.650.650.880.470.870.47
Upgrade
Return on Equity (ROE)
-62.31%-62.31%-52.43%-77.08%-48.49%-33.25%
Upgrade
Return on Assets (ROA)
-18.29%-18.29%-10.04%-10.97%-8.17%-7.43%
Upgrade
Return on Capital (ROIC)
-24.48%-24.48%-13.69%-14.06%-10.54%-10.30%
Upgrade
Earnings Yield
-76.83%-105.81%-77.22%-80.22%-14.88%-14.76%
Upgrade
FCF Yield
-8.19%-11.28%-17.84%-16.39%-3.01%-4.68%
Upgrade
Buyback Yield / Dilution
-416.13%-416.13%-221.82%-13.96%-5.75%-0.10%
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q